Press Releases
Establishes large scale U.S.-based hemp extraction capacity and creates a unique North American platform to provide customers with value-added products LAVAL, QC, July 24, 2019 /PRNewswire/ - Neptune Wellness Solutions Inc. ("Neptune" or the "Company") (NASDAQ: NEPT) (TSX: NEPT), a North American leader in extraction, formulation and turnkey
Read more...SILVER SPRING, Md. and RESEARCH TRIANGLE PARK, N.C., July 24, 2019 /PRNewswire/ -- United Therapeutics Corporation (Nasdaq: UTHR) announced today that it will report its second quarter 2019 financial results before the market opens on Wednesday, July 31, 2019.United Therapeutics will host a telec
Read more...FORT LAUDERDALE, Fla., July 24, 2019 /PRNewswire/ -- Delphi Behavioral Health Group, a leading nationwide provider of addiction and detox treatment programs, announced today t
Read more...24 July 2019
MINNEAPOLIS, July 24, 2019 /PRNewswire/ -- Today, Bright Health announced it will begin offering its innovative Health Plan Care Partner Model in 13 new markets across seven states in 2020 plus expanded product offerings in every existing market. This market expansion brings Bright Health Plan's footprint to a total of 22 markets in 12 states, building on its sizab
Read more...WALTHAM, Mass., July 24, 2019 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the second quarter ended June 29, 2019. Second Quarter 2019 HighlightsSecond quarter revenue increased 4% to $6.32
Read more...NORTH CHICAGO, Ill., July 24, 2019 /PRNewswire/ -- In accordance with Rule 2.10 of the Irish Takeover Panel Act, 1997, Takeover Rules 2013, AbbVie Inc. confirms that as of July 22, 2019 its issued share capital, excluding treasury shares, is comprised of 1,478,481,177 shares of common stock with a par value of $0.01
Read more...LOS ANGELES, July 24, 2019 /PRNewswire/ -- ImaginAb Inc., a clinical-stage immuno-oncology imaging company, announces it has initiated its Phase II clinical trial of its lead product, CD8 tracer 89Zr-Df-IAB22M2C, at Dana-Farber Cancer Institute in Boston, MA. Dana-Farber Cancer Institute is a world-renowned research and treatm
Read more...MILAN, July 24, 2019 /PRNewswire/ -- Olon S.p.A., a world leading Active Pharmaceutical Ingredients (API) contract development and manufacturing organization (CDMO) and generics supplier, celebrates today the start of the construction of a new GMP manufacturing facility at its microbial CDMO facility located in Capua, Italy.
Read more...AUSTIN, Texas, July 23, 2019 /PRNewswire/ -- Healthcare providers are focused on delivering care. That means always seeking better ways to improve patient outcomes, make reporting easier, and meet financial goals. It's a big job that never ends. That's why
Read more...LOS ANGELES, July 23, 2019 /PRNewswire/ -- Immix Biopharma, Inc--a clinical-stage biopharmaceutical company developing next-generation cancer therapies--announced today that it received a letter from the FDA authorizing it to proceed with expanding its phase 1b/2a clinical trial of IMX-110 to the United States
Read more...